Eco Animal Health Ltd, headquartered in Great Britain, is a leading player in the global animal health industry, specialising in innovative solutions for livestock and aquaculture. Founded in 2004, the company has made significant strides in developing unique products that enhance animal welfare and productivity. With a strong presence in Europe, Asia, and the Americas, Eco Animal Health focuses on a range of core services, including the development of pharmaceuticals and nutritional products tailored for various species. Their flagship products, such as Aivlosin® and EcoVax®, are renowned for their efficacy and safety, setting them apart in a competitive market. Recognised for their commitment to research and development, Eco Animal Health has achieved notable milestones, positioning themselves as a trusted partner in animal health management worldwide.
How does Eco Animal Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Eco Animal Health's score of 32 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Eco Animal Health reported total carbon emissions of approximately 20,000 kg CO2e, comprising 11,000 kg CO2e from Scope 1 and 9,000 kg CO2e from Scope 2 emissions. This data is cascaded from their parent company, ECO Animal Health Ltd., and reflects their commitment to transparency in environmental reporting. Comparatively, in 2021, the company recorded total emissions of 20,000 kg CO2e as well, with Scope 1 emissions at 9,000 kg CO2e and Scope 2 emissions at 11,000 kg CO2e. This indicates a stable emissions profile over the two years, with no significant reduction targets or achievements reported. Eco Animal Health has not disclosed any Scope 3 emissions, nor have they set specific reduction targets through initiatives such as the Science Based Targets initiative (SBTi). Their climate commitments remain vague, with no formal pledges or initiatives outlined in the available data. Overall, Eco Animal Health's emissions data highlights their current operational impact, while their lack of defined reduction strategies suggests an area for potential improvement in their climate commitments.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 9,000 | 00,000 |
| Scope 2 | 11,000 | 0,000 |
| Scope 3 | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Eco Animal Health has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.